Neocis logo

Neocis

Neocis is a Miami, Florida maker of Yomi, which it describes as the first and only FDA-cleared robotic system for dental implant surgery. Clinicians have completed more than 100,000 osteotomies with Yomi, and on October 29, 2026 the second-generation Yomi S won FDA clearance for pterygoid implants.2,4,5

Robotics Reviewed Editorial TeamUpdated November 3, 2026neocis.com

Our take

Neocis has the dental implant robot category largely to itself in the US. Yomi gives the surgeon haptic guidance on a planned path, replacing printed surgical guides, and has collected 16 FDA 510(k) clearances.1,3

Adoption is real: more than 100,000 osteotomies, a dental school customer, and a second-generation Yomi S that keeps adding indications. Weak points are prices that are not published and the cost of a capital robot for a single dental practice.4,2,5

Scores by criterion

Neocis scores out of 10
Pricing transparency3.0
Product maturity8.0
Deployment evidence7.5
Company durability6.5
Ease of integration6.5
Overall score (average of the five)6.3

Each criterion is defined on our methodology page.

Who uses Neocis and what it's for

Oral surgeons, periodontists, prosthodontists, and implant dentists use Yomi for single implants, full-arch cases, bone reduction, and now pterygoid implants.2,5

Boston University's Henry M. Goldman School of Dental Medicine was the first US dental school to install Yomi and teach robot-guided implantology.2

History

Alon Mozes and Juan Salcedo, then principal engineers at orthopedic robot maker MAKO Surgical, began designing Yomi in 2008 and founded Neocis in Miami in 2009. Fred Moll, founder of Intuitive Surgical, led its first funding round in 2012.2

Yomi won FDA clearance for single implants in 2016 and sold its first system in 2017. Neocis raised a $72 million Series D, then $20 million more in 2023 with Mirae Asset and NVIDIA's NVentures.2,6,3

Yomi and Yomi S

Yomi is an end-to-end platform for planning, surgery, and restoration. Its arm gives haptic feedback and physical guidance to keep the drill on plan, and the clinician can change the plan during surgery.1

Yomi S, launched in 2025, is the second generation. In October 2026 it and the YomiPlan software received FDA clearance for pterygoid implants, placed deep in the back of the upper jaw at steep angles.2,5

Pricing

Neocis does not publish prices for Yomi or Yomi S.1

Competitive landscape

Which of these companies scores best, and who is each one built for?Hover over or tap a logo for details.
Top rated, for patients and clinicsTop rated, for large hospitalsLower score, for patients and clinicsLower score, for large hospitalsNot yet reviewed45678910Review Score← Patients and clinicsLarge hospital systems →Who it's built for6.36.05.75.6
Neocis and its competitors
CompanyProductPricing modelDeployment footprintWhere Neocis wins or loses
NeocisYomi and Yomi S robots for dental implant surgery2Not published1More than 100,000 osteotomies in US practices4The only FDA-cleared dental implant robot; prices not published
PerceptiveOCT scanner, AI planning, and a restorative robot in development7Not on sale; not FDA cleared7First fully automated procedure on a human, in Colombia8Perceptive wins on ambition, with automated crowns. Neocis wins on a cleared product with years of clinical use.
ClaroNavNavident EVO dynamic navigation for implants and endodontics17Not published10FDA cleared for implant guidance since 201618ClaroNav wins on a portable, lower-cost navigation system. Neocis wins on a robot arm that physically guides the drill.
X-Nav TechnologiesX-Guide dynamic 3D navigation for implant drills12Not published19Sold in the US through Nobel Biocare19X-Nav wins on navigation sold through a large implant brand. Neocis wins on haptic robotic guidance.
RemebotSemi-active robot that drills and places implants20Not published20Approved in China in 2021 as its first oral surgery robot20Remebot wins on a semi-active robot that drills on its own in China. Neocis wins on FDA clearance and US adoption.

Limits

Prices are not published.1

Revenue is not disclosed. We estimate it at $20 million to $50 million, based on more than 100,000 osteotomies, about 140 employees in 2022, and more than $90 million raised in its last two rounds. This is an estimate, not a reported figure.4,6,3

Neocis sells mainly in the US, where its FDA clearances apply.3

What customers say

Where it helps

By removing the need for printed surgical guides, Yomi lets practices plan and operate in the same visit, so patients can get teeth in as little as one visit.1

Neocis says an implant is placed with Yomi about every 3.8 minutes.1

Where it falls short

Practices that want lower-cost guidance without a robot arm may get more from dynamic navigation systems such as ClaroNav's Navident or X-Nav's X-Guide.

Leadership

  • Alon Mozes

    Alon Mozes

    CEO and co-founder

    Mozes was a principal engineer at orthopedic robot maker MAKO Surgical before co-founding Neocis in 2009.2

    Read full profile

  • Juan Salcedo

    Juan Salcedo

    Co-founder

    Salcedo was also a principal engineer at MAKO Surgical and co-designed the first Yomi prototype.2

  • Dennis Moses

    Dennis Moses

    CTO

    Moses is Neocis' chief technology officer.4

Sources

  1. Neocis, Homepage, accessed November 3, 2026
  2. Neocis, About us, accessed November 3, 2026
  3. Neocis, Dental robotics leader Neocis secures $20M in funding, January 10, 2024, accessed November 3, 2026
  4. Neocis, Neocis surpasses 100,000 robotic osteotomies with the Yomi platform, January 7, 2026, accessed November 3, 2026
  5. Neocis, Neocis expands Yomi S clearance to include pterygoid implant placement, October 29, 2026, accessed November 3, 2026
  6. Refresh Miami, Catching up with Neocis' Alon Mozes: A Miami success story is unfolding, March 4, 2022, accessed November 3, 2026
  7. Perceptive, Homepage, accessed November 3, 2026
  8. The Independent, Startup completes first fully robotic dental surgery, August 6, 2024, accessed November 3, 2026
  9. ClaroNav, Our company, accessed November 4, 2026
  10. ClaroNav Dental, Homepage, accessed November 3, 2026
  11. ClaroNav, Navident EVO receives FDA clearance for guided endodontics, September 19, 2024, accessed November 4, 2026
  12. X-Nav Technologies, About X-Guide, accessed November 3, 2026
  13. dentalimplant.now, FDA clears X-Guide Surgical Navigation System, August 28, 2026, accessed November 4, 2026
  14. X-Nav Technologies, X-Nav expands into robotic innovation, accessed November 4, 2026
  15. China Medical and Surgical Robotics Database, Remebot, accessed November 4, 2026
  16. MedChina, 2025 China Surgical Robot Sales Annual Report, accessed November 4, 2026
  17. ClaroNav, Navident EVO receives FDA clearance for guided endodontics, September 10, 2024, accessed November 3, 2026
  18. GlobeNewswire, Navident 3 receives FDA clearance, June 30, 2022, accessed November 3, 2026
  19. Nobel Biocare, X-Guide, accessed November 3, 2026
  20. China Medical and Surgical Robotics Database, Remebot Dental Robot, accessed November 3, 2026